Diego F Calvisi received his Medical Doctor and Clinical
Pathologist degrees from the Medical School of the University of Sassari
(Sassari, Italy). Afterward, he joined the Laboratory of Experimental
Carcinogenesis, directed by Dr. Snorri S. Thorgeirsson at the National Cancer
Institute (Bethesda, MD, USA). Subsequently, he established his laboratory at
the Medical School of the University of Greifswald (Greifswald, Germany).
Currently, he is a Professor of Experimental Tumor Pathology at the University
of Regensburg (Regensburg, Germany), and an Associate Professor of General
Pathology at the University of Sassari. He is also the Associate Editor of
Carcinogenesis and Seminars in Liver Disease. He is also a reviewer for several
journals and official agencies in Europe. He authored more than 200
publications in peer-reviewed journals to date. His scientific interest centers
on liver cancer, specifically on mouse models of hepatocarcinogenesis, the molecular pathogenesis of hepatobiliary
tumors, and innovative therapies targeting signaling pathways and cancer
metabolism.
Research Keywords & Expertise
Cancer Biology
Cancer Research
Cell Biology
Cell Culture
Cell Signaling
Genetics
Immunohistochemistry
Signal Transduction
PCR
Cancer diagnostics
Short Biography
Diego F Calvisi received his Medical Doctor and Clinical
Pathologist degrees from the Medical School of the University of Sassari
(Sassari, Italy). Afterward, he joined the Laboratory of Experimental
Carcinogenesis, directed by Dr. Snorri S. Thorgeirsson at the National Cancer
Institute (Bethesda, MD, USA). Subsequently, he established his laboratory at
the Medical School of the University of Greifswald (Greifswald, Germany).
Currently, he is a Professor of Experimental Tumor Pathology at the University
of Regensburg (Regensburg, Germany), and an Associate Professor of General
Pathology at the University of Sassari. He is also the Associate Editor of
Carcinogenesis and Seminars in Liver Disease. He is also a reviewer for several
journals and official agencies in Europe. He authored more than 200
publications in peer-reviewed journals to date. His scientific interest centers
on liver cancer, specifically on mouse models of hepatocarcinogenesis, the molecular pathogenesis of hepatobiliary
tumors, and innovative therapies targeting signaling pathways and cancer
metabolism.